TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors

Not yet recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 6, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Solid Tumors

Interventions

DRUG

18-FDG

All study participants will undergo one 18F-FDG PET/ CT scan.

Trial Locations (1)

Beijing Cancer Hospital, Beijing

All Listed Sponsors

lead

Peking University Cancer Hospital & Institute

OTHER

NCT06755086 - TF-antigen Targeting Molecular Probe for PET Imaging in Solid Tumors | Biotech Hunter | Biotech Hunter